223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapy

BACKGROUND: Bone-seeking radiopharmaceuticals can deposit radiation selectively to some osteosarcoma tumours because of the bone-forming nature of this cancer. OBJECTIVES: This is the first report of using 223-radium, an alpha-emitting calcium analogue with a high therapeutic index, in combination t...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Pete M, Scott, Jacob, Parsai, Shireen, Zahler, Stacey, Worley, Sarah, Shrikanthan, Sankaran, Subbiah, Vivek, Murphy, Erin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199915/
https://www.ncbi.nlm.nih.gov/pubmed/32303572
http://dx.doi.org/10.1136/esmoopen-2019-000635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199915/
https://www.ncbi.nlm.nih.gov/pubmed/32303572
http://dx.doi.org/10.1136/esmoopen-2019-000635

Ejemplares similares